Mission3 Announces Strategic Partnership With TGen Affiliate TD2 Mission3, Inc. today announced that they have joined a strategic partnership with TD2, the drug development affiliate of the Translational Genomics Research Institute (TGen) to aid in developing oncology therapeutics.
For Immediate Release PHOENIX/EWORLDWIRE/June 19, 2006 --- Mission3, Inc., a leading provider of document and project management software serving the life sciences industry today announced that it has joined a strategic partnership with TGen Drug Development Services (TD2), the non-profit drug development affiliate of the Translational Genomics Research Institute (TGen) to aid in developing oncology therapeutics. "MissionFire allows life science organizations to manage their mission-critical content and processes in a cost effective manner. This enterprise software application enables companies to take control of their project management and documentation in one centralized Web-based environment, allowing for an efficient and effective use of resources," said Dirk Karsten Beth, president of Mission3, Inc. "With rich features in project management and document management, it was designed specifically for the Life Sciences industry to facilitate electronic submissions with the FDA." "This software is a valuable tool that will help us get promising new cancer treatments to patients as quickly and safely as possible, while continuing to meet stringent Federal regulations," said TD2 general manager Steve Marsh. ------------------------ Yahoo! Groups Sponsor --------------------~--> Yahoo! Groups gets a make over. See the new email design. http://us.click.yahoo.com/vTZcGA/lOaOAA/79vVAA/H4xqlB/TM --------------------------------------------------------------------~-> http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
